Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing

Gregory Wellman, Thomas Sherrin

Open source

DOI
10.1016/s0149-2918(97)80107-5
Published
1997-07
Container
Clinical Therapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0149-2918-97-80107-5,
  title = {Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing},
  author = {Gregory Wellman and Thomas Sherrin},
  year = {1997},
  journal = {Clinical Therapeutics},
  doi = {10.1016/s0149-2918(97)80107-5},
  url = {https://doi.org/10.1016/s0149-2918(97)80107-5}
}

RIS

TY  - JOUR
TI  - Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing
AU  - Gregory Wellman
AU  - Thomas Sherrin
PY  - 1997
JO  - Clinical Therapeutics
DO  - 10.1016/s0149-2918(97)80107-5
UR  - https://doi.org/10.1016/s0149-2918(97)80107-5
ER  - 

APA

Wellman, G., & Sherrin, T. (1997). Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(97)80107-5

Source records